WalkerDKBallSDonahueSIzraelDSrinathKPDingHInfluenza vaccination coverage among pregnant women: 2011–12 influenza season, United States. MMWR Morb Mortal Wkly Rep2012; 61(38):758–63.
4.
GallSAPolandGA. A maternal immunization program (MIP): developing a schedule and platform for routine immunization during pregnancy. Vaccine2011; 29:9411–3.
5.
Link-GellesRChamberlainATSchulkinJAultKWhitneyESeibKMissed opportunities: a national survey of obstetricians about attitudes on maternal and infant immunization. Matern Child Health J2012; 16:1743–7.
6.
NávarAMHalseyNACarterTCMontgomeryMPSalmonDA. Prenatal immunization education. Am J Prev Med2007; 33:211–3.
7.
NeuzilKMReedGWMitchelEFSimonsenLGriffinMR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol1998; 148:1094–102.
8.
RogersVLSheffieldJSRobertsSWMcIntireDDLubyJPTrevinoSPresentation of seasonal influenza A in pregnancy: 2003–2004 influenza season. Obstet Gynecol2010; 115:924–9.
9.
CoxSPosnerSFMcPheetersMJamiesonDJKourtisAPMeikleS. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol2006; 107:1315–22.
10.
RasmussenSAJamiesonDJUyekiTM. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol2012;207 (3 Suppl):S3–8.
11.
SistonAMRasmussenSAHoneinMAFryAMSeibKCallaghanWMPandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA2010; 303:1517–25.
12.
CreangaAAJohnsonTFGraitcerSBHartmanLKAl-SamarraiTSchwarzAGSeverity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol2010; 115:717–26.
13.
Blanchard-RohnerGSiegristCA. Vaccination during pregnancy to protect infants against influenza: why and why not?Vaccine2011; 29:7542–50.
14.
MorGCardenasI. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol2010; 63:425–33.
15.
JamiesonDJKissinDMBridgesCBRasmussenSA. Benefits of influenza vaccination during pregnancy for pregnant women. Am J Obstet Gynecol2012; 207(3 Suppl):S17–20.
16.
JacksonLAPatelSMSwamyGKFreySECreechCBMunozFMImmunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis2011; 204:854–63.
17.
PoehlingKAEdwardsKMWeinbergGASzilagyiPStaatMAIwaneMKThe underrecognized burden of influenza in young children. N Engl J Med2006; 355:31–40.
18.
PoehlingKAEdwardsKMGriffinMRSzilagyiPGStaatMAIwaneMKThe burden of influenza in young children, 2004–2009. Pediatrics2013; 131:207–16.
Van de PerreP. Transfer of antibody via mother's milk. Vaccine2003; 21:3374–6.
21.
Van den BergJPWesterbeekEAvan der KlisFRBerbersGAvan ElburgRM. Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev2011; 87:67–72.
22.
Van den BergJPWesterbeekEABerbersGAvan GageldonkPGvan der KlisFRvan ElburgRM. Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr Infect Dis J2010; 29:801–5.
23.
MooiFRde GreeffSC. The case for maternal vaccination against pertussis. Lancet Infect Dis2007; 7:614–24.
24.
HealyCMRenchMABakerCJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis2013; 56:539–44.
25.
ZuccottiGPoglianiLParianiEAmendolaAZanettiA. Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine. JAMA2010; 304:2360–1.
26.
ZamanKRoyEArifeenSERahmanMRaqibRWilsonEEffectiveness of maternal influenza immunization in mothers and infants [published erratum appears in N Engl J Med2009; 360:648]. N Engl J Med2008; 359:1555–64.
27.
EnglundJA. The influence of maternal immunization on infant immune responses. J Comp Pathol2007;137Suppl:S16-9.
28.
FischerGWOttoliniMGMondJJ. Prospects for vaccines during pregnancy and in the newborn period. Clin Perinatol1997; 24:231–49.
GreenwoodB. Maternal immunisation in developing countries. Vaccine2003; 21:3436–41.
31.
MunozFMFerrieriP. Group B streptococcus vaccination in pregnancy: moving toward a global maternal immunization program. Vaccine2013; 31Suppl 4:D46–51.
32.
OrtizJRNeuzilKMAhonkhaiVIGellinBGSalisburyDMReadJSTranslating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings. Vaccine2012; 30:7134–40.
33.
EickAAUyekiTMKlimovAHallHReidRSantoshamMMaternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med2011; 165:104–11.
34.
BenowitzIEspositoDBGraceyKDShapiroEDVázquezM. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis2010; 51:1355–61.
35.
PetersTRBanksGCSnivelyBMPoehlingKA. Potential impact of parental Tdap immunization on infant pertussis hospitalizations. Vaccine2012; 30:5527–32.
36.
HealyCMMunozFMRenchMAHalasaNBEdwardsKMBakerCJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis2004; 190:335–40.
37.
GallSAMyersJPichicheroM. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol2011; 204:334.e1-5.
38.
MunozFMBondNHMaccatoMPinellPHammillHASwamyGKSafety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA2014; 311:1760–9.
39.
FellDBSpragueAELiuNYasseenASIIIWenSWSmithGH1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health2012; 102:e33–40.
40.
RichardsJLHansenCBredfeldtCBednarczykRASteinhoffMCAdjaye-GbewonyoDNeonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth. Clin Infect Dis2013; 56:1216–22.
41.
OmerSBGoodmanDSteinhoffMCRochatRKlugmanKPStollBJMaternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med2011; 8:e1000441.
42.
BisgardKMPascualFBEhresmannKRMillerCACianfriniCJenningsCEInfant pertussis: who was the source?Pediatr Infect Dis J2004; 23:985–9.
43.
WendelboeAMNjamkepoEBourillonAFloretDDGaudelusJGerberMTransmission of Bordetella pertussis to young infants. Pediatr Infect Dis J2007; 26:293–9.
44.
HealyCMRenchMABakerCJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis2011; 52:157–62.
45.
GrizasAPCamengaDVázquezM. Cocooning: a concept to protect young children from infectious diseases. Curr Opin Pediatr2012; 24:92–7.
46.
MunozFEnglundJ. Infant pertussis: is cocooning the answer?Clin Infect Dis2011; 53:893–6.
47.
ChambersCDJohnsonDXuRLuoYLouikCMitchellAARisks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine2013; 31:5026–32.
48.
KharbandaEOVazquez-BenitezGShiWXLipkindHNalewayAMolitorBAssessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink. Am J Obstet Gynecol2012; 207(3 Suppl):S47–51.
49.
NalewayALIrvingSAHenningerMLLiDKShifflettPBallSSafety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies. Vaccine2014; 32:3122–7.
50.
NordinJDKharbandaEOBenitezGVNicholKLipkindHNalewayAMaternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol2013; 121:519–25.
51.
SchatzMChambersCDJonesKLLouikCMitchellAA. Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System. Am J Obstet Gynecol2011; 204(6 Suppl 1):S64–8.
52.
SteinhoffMCOmerSBRoyEEl ArifeenSRaqibRDoddCNeonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ2012; 184:645–53.
53.
PasternakBSvanströmHMølgaard-NielsenDKrauseTGEmborgHDMelbyeMRisk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA2012; 308:165–74.
54.
PasternakBSvanströmHMølgaard-NielsenDKrauseTGEmborgHDMelbyeMVaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ2012; 344:e2794.
55.
LouikCAhrensKKerrSPyoJChambersCJonesKLRisks and safety of pandemic H1N1 influenza vaccine in pregnancy: exposure prevalence, preterm delivery, and specific birth defects. Vaccine2013; 31:5033–40.
56.
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months—Advisory Committee on Immunization Practices (ACIP), 2011MMWR Morb Mortal Wkly Rep 2011; 60(41):1424–6.
57.
ShakibJHKorgenskiKShengXVarnerMWPaviaATByingtonCL. Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. J Pediatr2013; 163:1422–6.e1-4.
58.
ZheteyevaYAMoroPLTepperNKRasmussenSABarashFERevzinaNVAdverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol2012; 207:59.e1-7.
59.
SilveiraCMCáceresVMDutraMGLopes-CameloJCastillaEE. Safety of tetanus toxoid in pregnant women: a hospital-based case-control study of congenital anomalies. Bull World Health Organ1995; 73:605–8.
60.
CzeizelAERockenbauerM. Tetanus toxoid and congenital abnormalities. Int J Gynaecol Obstet1999; 64:253–8.
61.
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep2013; 62(7):131–5.
62.
21 C.F.R., 201.57 (2014).
63.
MarshallVGruberM. Influenza immunization during pregnancy: US regulatory perspective. Am J Obstet Gynecol2012; 207(3 Suppl):S57–62.
BurneyLE. Influenza immunization: statement. Public Health Rep1960; 75:944.
66.
HarperSAFukudaKUyekiTMCoxNJBridgesCB. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep2004; 53(RR-6):1–40.
67.
KennedyEDAhluwaliaIBDingHLuPJSingletonJABridgesCB. Monitoring seasonal influenza vaccination coverage among pregnant women in the United States. Am J Obstet Gynecol2012; 207(3 Suppl):S9–16.
68.
ZhaoGFordESTsaiJLiCAhluwaliaIBPearsonWSTrends in health-related behavioral risk factors among pregnant women in the United States: 2001–2009. J Womens Health (Larchmt)2012; 21:255–63.
JamiesonDJHoneinMARasmussenSAWilliamsJLSwerdlowDLBiggerstaffMSH1N1 2009 influenza virus infection during pregnancy in the USA. Lancet2009; 374:451–8.
71.
LouieJKAcostaMJamiesonDJHoneinMA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med2010; 362:27–35.
72.
AhluwaliaIBHarrisonLDingHAustinTD'AngeloDHastingsPInfluenza vaccination coverage among pregnant women—29 states and New York City, 2009–10 season. MMWR Morb Mortal Wkly Rep2012; 61(7):113–8.
TerranellaAAsayGRMessonnierMLClarkTALiangJL. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Pediatrics2013; 131:e1748–56.
75.
WalshJMMcPheeSJ. A systems model of clinical preventive care: an analysis of factors influencing patient and physician. Health Educ Q1992; 19:157–75.
76.
HenningerMNalewayACraneBDonahueJIrvingS. Predictors of seasonal influenza vaccination during pregnancy. Obstet Gynecol2013; 121:741–9.
77.
EppesCWuAYouWCameronKAGarciaPGrobmanW. Barriers to influenza vaccination among pregnant women. Vaccine2013; 31:2874–8.
78.
SilvermanNSGreifA. Influenza vaccination during pregnancy. Patients' and physicians' attitudes. J Reprod Med2001; 46:989–94.
79.
DreesMJohnsonOWongEStewartAFerisinSSilvermanPRAcceptance of 2009 H1N1 influenza vaccine among pregnant women in Delaware. Am J Perinatol2012; 29:289–94.
80.
AhluwaliaIBJamiesonDJRasmussenSAD'AngeloDGoodmanDKimH. Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island. Obstet Gynecol2010; 116:949–55.
81.
YudinMHSalaripourMSgroMD. Pregnant women's knowledge of influenza and the use and safety of the influenza vaccine during pregnancy. J Obstet Gynaecol Can2009; 31:120–5.
82.
MonizMHVitekWSAkersAMeynLABeigiRH. Perceptions and acceptance of immunization during pregnancy. J Reprod Med2013; 58:383–8.
83.
LyerlyADMitchellLMArmstrongEMHarrisLHKuklaRKuppermannMRisks, values, and decision making surrounding pregnancy. Obstet Gynecol2007; 109:979–84.
84.
MeharryPMColsonERGrizasAPStillerRVázquezM. Reasons why women accept or reject the trivalent inactivated influenza vaccine (TIV) during pregnancy. Matern Child Health J2013; 17:156–64.
85.
LiuNSpragueAEYasseenASIIIFellDBWenSWSmithGNVaccination patterns in pregnant women during the 2009 H1N1 influenza pandemic: a population-based study in Ontario, Canada. Can J Public Health2012; 103:e353–8.
86.
MunozFMGreisingerAJWehmanenOAMouzoonMEHoyleJCSmithFASafety of influenza vaccination during pregnancy. Am J Obstet Gynecol2005; 192:1098–106.
87.
VitekWSAkersAMeynLASwitzerGELeeBYBeigiRH. Vaccine eligibility and acceptance among ambulatory obstetric and gynecologic patients. Vaccine2011; 29:2024–8.
88.
MouzoonMEMunozFMGreisingerAJBrehmBJWehmanenOASmithFAImproving influenza immunization in pregnant women and healthcare workers. Am J Manag Care2010; 16:209–16.
StewartAMLindleyMCChangKHMCoxMA. Vaccination benefits and cost-sharing policy for non-institutionalized adult Medicaid enrollees in the United States. Vaccine2014; 32:618–23.
92.
MaherLHopeKTorvaldsenSLawrenceGDawsonAWileyKInfluenza vaccination during pregnancy: coverage rates and influencing factors in two urban districts in Sydney. Vaccine2014; 31:5557–64.
93.
BeelERRenchMAMontesinosDPMayesBHealyCM. Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period. Hum Vaccin Immunother2013; 9:1926–31.
94.
WileyKEMasseyPDCooperSCWoodNQuinnHELeaskJ. Pregnant women's intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey. Vaccine2013; 31:3972–8.
95.
SchragSJFioreAEGonikBMalikTReefSSingletonJAVaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol2003; 101:704–10.
96.
BeigiRHSwitzerGEMeynLA. Acceptance of a pandemic avian influenza vaccine in pregnancy. J Reprod Med2009; 54:341–6.
97.
TongABiringerAOfner-AgostiniMUpshurRMcGeerA. A cross-sectional study of maternity care providers' and women's knowledge, attitudes, and behaviours towards influenza vaccination during pregnancy. J Obstet Gynaecol Can2008; 30:404–10.
98.
PowerMLLeddyMAAndersonBLGallSAGonikBSchulkinJ. Obstetrician-gynecologists' practices and perceived knowledge regarding immunization. Am J Prev Med2009; 37:231–4.
99.
GonikBJonesTContrerasDFasanoNRobertsC. The obstetrician-gynecologist's role in vaccine-preventable diseases and immunization. Obstet Gynecol2000; 96:81–4.
100.
WuPGriffinMRRichardsonAGabbeSGGambrellMAHartertTV. Influenza vaccination during pregnancy: opinions and practices of obstetricians in an urban community. South Med J2006; 99:823–8.
101.
BednarczykRAAdjaye-GbewonyoDOmerSB. Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol2012; 207(3 Suppl):S38–46.
102.
KissinDMPowerMLKahnEBWilliamsJLJamiesonDJMacFarlaneKAttitudes and practices of obstetrician-gynecologists regarding influenza vaccination in pregnancy. Obstet Gynecol2011; 118:1074–80.
103.
WallisDHChinJLSurDK. Influenza vaccination in pregnancy: current practices in a suburban community. J Am Board Fam Pract2004; 17:287–91.
104.
PandaBStillerRPandaA. Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines. J Matern Neonatal Med2011; 24:402–6.
105.
FreedGLCowanAEClarkSJ. Primary care physician perspectives on reimbursement for childhood immunizations. Pediatrics2008; 122:1319–24.
106.
Al-SafiZAShavellVIGonikB. Vaccination in pregnancy. Womens Health (Lond Engl)2011; 7:109–19.
107.
42 U.S.C. Ch. 6A, Subchapter XIX (1994).
108.
42 U.S.C. š300aa-10 et seq.
109.
42 U.S.C. š 300aa-11 (a) (2) (A).
110.
JohnsonDRNicholKLLipczynskiK. Barriers to adult immunization. Am J Med2008;121 (7 Suppl 2):S28–35.
111.
LeddyMAGonikBGallSAAndersonBASchulkinJ. Changes in immunization practices, knowledge and beliefs of Michigan obstetrician-gynecologists since 2000. Michigan J Public Health2009; 3:20–32.
112.
Centers for Disease Control and Prevention (US), Advisory Committee on Immunization Practices Workgroup on the Use of Vaccines During Pregnancy and Breastfeeding. Guiding principles for development of ACIP recommendations for vaccination during pregnancy and breastfeeding. 2008 [cited 2013 Nov 16]. Available from: URL: http://www.cdc.gov/vaccines/acip/committee/downloads/preg-principles-2008.pdf
LipkusIM. Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations. Med Decis Making2007; 27:696–713.
117.
LynchMMMitchellEWWilliamsJLBrumbaughKJones-BellMPinkneyDE Pregnant and recently pregnant women's perceptions about influenza A pandemic (H1N1) 2009: implications for public health and provider communication. Matern Child Health J2012; 16:1657–64.
118.
MeharryPMCussonRMStillerRVázquezM. Maternal influenza vaccination: evaluation of a patient-centered pamphlet designed to increase uptake in pregnancy. Matern Child Health J2014; 18:1205–14.
119.
BetschCRenkewitzFHaaseN. Effect of narrative reports about vaccine adverse events and bias-awareness disclaimers on vaccine decisions: a simulation of an online patient social network. Med Decis Making2013; 33:14–25.
120.
WinterbottomABekkerHLConnerMMooneyA. Does narrative information bias individual's decision making? A systematic review. Soc Sci Med2008; 67:2079–88.
121.
FagerlinAZikmund-FisherBJUbelPA. Helping patients decide: ten steps to better risk communication. J Natl Cancer Inst2011; 103:1436–43.
DeclercqERSakalaCCorryMPApplebaumS. Listening to Mothers II pregnancy and birth: report of the second national U.S. survey of women's childbearing experiences. New York: Childbirth Connection; 2006. Also available from: URL: https://www.childbirthconnection.org/pdfs/LTMII_report.pdf [cited 2013 Nov 17].
BlumbergSJLukeJV. Wireless substitution: early release of estimates from the National Health Interview Survey, January-June 2012. Rockville (MD): National Center for Health Statistics; 2012. Also available from: URL: http://www.cdc.gov/nchs/data/nhis/earlyrelease/wireless201212.pdf [cited 2013 Nov 17].
128.
StockwellMSFiksAG. Utilizing health information technology to improve vaccine communication and coverage. Hum Vaccin Immunother2013; 9:1802–11.
129.
National Healthy Mothers Healthy Babies Coalition. Text4baby [cited 2014 Jun 1]. Available from: URL: https://www.text4baby.org
130.
EvansWDWallaceJLSniderJ. Pilot evaluation of the Text4baby mobile health program. BMC Public Health2012; 12:1031.
MonizMHHasleySMeynLABeigiRH. Improving influenza vaccination rates in pregnancy through text messaging: a randomized controlled trial. Obstet Gynecol2013; 121:734–40.
Department of Health and Human Services (US), National Vaccine Advisory Committee. White paper on the United Stated vaccine safety system: final. Washington: Department of Health and Human Services (US); 2011. Also available from: URL: http://www.hhs.gov/nvpo/nvac/nvac_vswp.pdf [cited 2013 May 19].
135.
Department of Health and Human Services (US). Vaccine Adverse Event Reporting System: frequently asked questions [cited 2014 May 12]. Available from: URL: http://vaers.hhs.gov/about/faqs#who_reports
136.
VarricchioFIskanderJDestefanoFBallRPlessRBraunMMUnderstanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J2004; 23:287–94.
137.
MoroPLBroderKZheteyevaYWaltonKRohanPSutherlandAAdverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990–2009. Am J Obstet Gynecol2011; 204:146.e1-7.
138.
MoroPLBroderKZheteyevaYRevzinaNTepperNKissinDAdverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol2011; 205:473.e1-9.
139.
ZheteyevaYMoroPLYueXBroderK. Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol2013; 208:478.e1-6.
140.
NalewayALGoldRKuroskySRiedlingerKHenningerMLNordinJDIdentifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink. Vaccine2013; 31:2898–903.
NguyenMBallRMidthunKLieuTA. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise. Pharmacoepidemiol Drug Saf2012;21Suppl 1:291–7.
Mini-Sentinel. Welcome to Mini-Sentinel [cited 2014 Jul 8]. Available from: URL: www.mini-sentinel.org
145.
EckertLOAndersonBLGonikBSchulkinJ. Reporting vaccine complications: what do obstetricians and gynecologists know about the Vaccine Adverse Event Reporting System?Infect Dis Obstet Gynecol2013; 2013:285257.
146.
American College of Obstetricians and Gynecologists. ACOG committee opinion no. 558: integrating immunizations into practice. Obstet Gynecol2013; 121:897–903.
147.
Department of Health and Human Services (US), National Vaccine Advisory Committee. Recommendations from the National Vaccine Advisory Committee: standards for adult immunization practice. Public Health Rep2014; 129:115–23.
148.
ColemanVHLaubeDWHaleRWWilliamsSBPowerMLSchulkinJ. Obstetrician-gynecologists and primary care: training during obstetrics-gynecology residency and current practice patterns. Acad Med2007; 82:602–7.
149.
LeddyMAAndersonBLPowerMLGallSGonikBSchulkinJ. Changes in and current status of obstetrician-gynecologists' knowledge, attitudes, and practice regarding immunization. Obstet Gynecol Surv2009; 64:823–9.
150.
IsholaDAJrPermallooNCorderyRJAndersonSR. Midwives' influenza vaccine uptake and their views on vaccination of pregnant women. J Public Health (Oxf)2013; 35:570–7.
151.
Centers for Disease Control and Prevention (US). Vaccines and immunizations: education & training for health professionals [cited 2014 Jul 8]. Available from: URL: http://www.cdc.gov/vaccines/ed/default.htm
ZimmermanRKBarkerWHStrikasRAAhweshERMieczkowskiTAJanoskyJEDeveloping curricula to promote preventive medicine skills. JAMA1997; 278:705–11.
154.
EPIC Program. EPIC® Educating Physicians In their Communities [cited 2014 Jul 8]. Available from: URL: www.gaepic.org
155.
BrissPARodewaldLEHinmanARSheferAMStrikasRABernierRRReviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med2000;18 (1 Suppl):97–140.
156.
YehSMinkCKimMNaylorSZangwillKMAllredNJ. Effectiveness of hospital-based postpartum procedures on pertussis vaccination among postpartum women. Am J Obstet Gynecol2014; 210:237. e1-6.
157.
KlattTEHoppE. Effect of a best-practice alert on the rate of influenza vaccination of pregnant women. Obstet Gynecol2012;119 (2 Pt 1):301–5.
158.
TrickWELinnESJonesZCaquelinCKeeRMoritaJY. Using computer decision support to increase maternal postpartum tetanus, diphtheria, and acellular pertussis vaccination. Obstet Gynecol2010; 116:51–7.
159.
ShavellVIMonizMHGonikBBeigiRH. Influenza immunization in pregnancy: overcoming patient and health care provider barriers. Am J Obstet Gynecol2012; 207(3 Suppl):S67–74.
160.
Community Preventive Services Task Force. Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Task Force on Community Preventive Services. Am J Prev Med2000; 18(1 Suppl):92–6.
161.
Centers for Disease Control and Prevention (US). Recommendations of the Advisory Committee on Immunization Practices: programmatic strategies to increase vaccination rates—assessment and feedback of provider-based vaccination coverage information. MMWR Morb Mortal Wkly Rep1996; 45(10):219–20.
162.
DiniEFChaneyMMoolenaarRLLeBaronCW. Information as intervention: how Georgia used vaccination coverage data to double public sector vaccination coverage in seven years. J Public Health Manag Pract1996; 2:45–9.
LeBaronCWMercerJTMassoudiMSDiniEStevensonJFischerWMChanges in clinic vaccination coverage after institution of measurement and feedback in 4 states and 2 cities. Arch Pediatr Adolesc Med1999; 153:879–86.
Department of Health and Human Services (US), National Vaccine Advisory Committee. A pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee. Public Health Rep2012; 127(Suppl 1):1–42.
169.
PickeringLKBakerCJFreedGLGallSAGroggSEPolandGAImmunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis2009; 49:817–40.
170.
National Committee for Quality Assurance. National Committee for Quality Assurance [cited 2014 Jul 8]. Available from: URL: www.ncqa.org
171.
National Quality Forum. National Quality Forum [cited 2014 Jul 8]. Available from: URL: www.qualityforum.org
172.
RobertsSHollierLMSheffieldJLaiblVWendelGDJr. Cost-effectiveness of universal influenza vaccination in a pregnant population. Obstet Gynecol2006; 107:1323–9.
173.
BeigiRHWiringaAEBaileyRRAssiTMLeeBY. Economic value of seasonal and pandemic influenza vaccination during pregnancy. Clin Infect Dis2009; 49:1784–92.
174.
WestraTAde VriesRTammingaJJSauboinCJPostmaMJ. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clin Ther2010; 32:1479–95.
175.
ShenAKSobzcykEBuchananAWuLDuggan-GoldsteinS. Second National Immunization Congress 2010: addressing vaccine financing for the future in the US. Hum Vaccin2011; 7:12–8.
176.
FreedGLClarkSJCowanAEColemanMS. Primary care physician perspectives on providing adult vaccines. Vaccine2011; 29:1850–4.
177.
HarrisKMUscher-PinesLMattkeSKellermanAL. A blueprint for improving the promotion and delivery of adult vaccination in the United States. Arlington (VA): RAND Corp.; 2012.
178.
YoungJLBernheimRGKorteJEStolerMHGuterbockTMRiceLW. Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. J Pediatr Adolesc Gynecol2011; 24:380–5.
179.
America's Health Insurance Plans. AHIP vaccines and immunizations roundtable report. Washington: America's Health Insurance Plans; 2009. Also available from: URL: http://www.ahip.org/vaccine-financing [cited 2013 Dec 4].
180.
FreedGLCowanAEGregorySClarkSJ. Variation in provider vaccine purchase prices and payer reimbursement. Pediatrics2009; 124Suppl 5:S459–65.
181.
BermanS. Is our vaccine system at risk for a future financial “meltdown?” Pediatrics 2008; 122:1372–3.
182.
ColemanMSFontanesiJMeltzerMISheferAFishbeinDBBennettNMEstimating medical practice expenses from administering adult influenza vaccinations. Vaccine2005; 23:915–23.
183.
McInernyTKCullWLYudkowskyBK. Physician reimbursement levels and adherence to American Academy of Pediatrics well-visit and immunization recommendations. Pediatrics2005; 115:833–8.
184.
YooB-KBerryAKasajimaMSzilagyiPG. Association between Medicaid reimbursement and child influenza vaccination rates. Pediatrics2010; 126:e998–1010.
ShenAKHunsakerJGazmararianJALindleyMCBirkheadGS. Role of health insurance in financing vaccinations for children and adolescents in the United States. Pediatrics2009;124Suppl:S522-31.
188.
GlaznerJEBeatyBBermanS. Cost of vaccine administration among pediatric practices. Pediatrics2009;124Suppl:S492-8.
189.
ColemanMSLindleyMCEkongJRodewaldL. Net financial gain or loss from vaccination in pediatric medical practices. Pediatrics2009; 124Suppl 5:S472–91.
190.
HunsakerJVeselovskiyGGazmararianJA. Health insurance plans and immunization: assessment of practices and policies, 2005–2008. Pediatrics2009; 124Suppl 5:S532–9.
191.
SobczykE. Vaccine finance resources for physicians. Pediatrics2009; 124Suppl 5:S573–6.
192.
American College of Obstetricians and Gynecologists. Immunization resources for obstetrician-gynecologists—a comprehensive tool kit. Washington: American College of Obstetricians and Gynecologists; 2013. Also available from: URL: https://www.acog.org/∼/media/Departments/Immunization/ImmunizationToolkit.pdf [cited 2014 May 11].
BuntinMBJainSHBlumenthalD. Health information technology: laying the infrastructure for national health reform. Health Aff (Millwood)2010; 29:1214–9.
195.
HardelidPFlemingDMAndrewsNBarleyMDurnallHMangtaniPEffectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008–2010: results from a cohort study in general practice. Vaccine2012; 30:1371–8.
196.
KharbandaEOParkerEDNordinJDHedblomBDRolnickSJ. Influenza and pertussis vaccination coverage among privately insured women of reproductive age. Matern Child Health J2013; 17:1631–7.
HazlehurstBNalewayAMulloolyJ. Detecting possible vaccine adverse events in clinical notes of the electronic medical record. Vaccine2009; 27:2077–83.
201.
HinrichsenVLKruskalBO'BrienMALieuTAPlattR. Using electronic medical records to enhance detection and reporting of vaccine adverse events. J Am Med Informatics Assoc2007; 14:731–5.
202.
JacobsAL. Liability and maternal immunization: in utero injury claims in the VICP. Am J Obstet Gynecol2012; 207(3 Suppl):S63–6.